On Monday, the renowned German drug maker, Bayer AG, had introduced a reformulated aspirin and claimed that the new version is around 2 times more efficient as compared to the regular aspirin. The drug uses a mechanism that chops aspirin molecules into smaller particles, roughly 10 times minor as compared to the original, which enables it to get absorbed more easily.
A German firm is going to commence clinical trials of an injectable drug that has the potential to vanish double chin.
Bayer, the pharmaceutical company and the maker of the drug ATX-101 stated that the drug had the power to breakdown small amount of fat cells and it could be administered with little or no anesthesia.
Chemical and Pharmaceutical company Bayer AG slid to an enormous 4.4% fall in Frankfurt trading because of a slump at the German drug and chemical maker's plastics unit.
Bayer, based in Leverkusen, fell by 1.41 Euros to 47.98 Euros. The stock was the biggest loser in Germany's benchmark DAX Index of 30 biggest companies, which gained 0.8%.
The Center for Science in the Public Interest (CSPI), a nonprofit consumer group, Thursday announced its plans of filing a lawsuit against the multinational company, Bayer HealthCare, for its allegedly "deceptive and irresponsible" advertising that claims selenium in two of its multivitamins may lower the risk of prostate cancer.
New Zealand News
- After Suspected Botulism, CFIA Warns People
- Health Care Education Necessary for the Future of Province: Analysts
- B.C. Government Grants $700,000 for Managing Facial Deformities
- Michelle Shocked delivers hate speech about homosexuality at her gig
- Guess who Justin Bieber got burned by?!! His ex-girlfriend Selena Gomez